DeviceClearance

BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAY— 510(k) K081824

Substantially Equivalent

Becton, Dickinson & CO

FDA 510(k) clearance K081824 for BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) Q AMPLIFIED DNA ASSAY, Substantially Equivalent on 2008-12-11. Applicant: Becton, Dickinson & CO.

Clearance details

Applicant
Becton, Dickinson & CO
Product code
Code MKZ
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Sparks, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.